| Caption | cPass™, the surrogate virus neutralisation test (sVNT) kit to detect the novel coronavirus (COVID-19) infection |
| Source | GenScript Biotech Corporation |
| Download | |
| Related Press Releases Links |
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen |